Pre-Filled Syringe, Autoinjector And Pen Injector Solutions For GLP-1 Applications
Glucagon-like peptide-1 (GLP-1) treatments have demonstrated remarkable effectiveness in addressing major public health issues, including diabetes and obesity.
Accelerate and derisk your GLP-1 drug development programs with Aptar Pharma’s reliable packaging solutions, including rigid needle shields (RNS), pre-filled syringe (PFS) and cartridge plungers. Our advanced parenteral closure solutions help optimize and secure your fill-finish operations.
Injectables
Injectables
Delivery Routes
-
Delivery Routes
- Eye Care
- Dermal
- Other Routes
Nasal Drug Delivery
Nasal Drug Delivery
Inhalation Drug Delivery
Inhalation Drug Delivery
-
Inhalation Drug Delivery
- Inhalation Drug Delivery Overview
Injectables
Injectables
Oral Liquid Dispensing
Oral Liquid Dispensing
-
Oral Liquid Dispensing
- Oral Liquid Dispensing
- Liquid Nutritional Supplements
- Oral Liquid Delivery Frequently Asked Questions
Accelerate And Derisk The Development Of Your GLP-1 Drugs For Diabetes And Obesity Treatments
Platform of pre-filled system components
Glucagon-like peptide-1 (GLP-1) based self-injection drugs for type 2 diabetes and obesity often rely on autoinjectors or pen injector systems to ensure their safe and effective administration by patients.
Aptar Pharma offers a range of high-quality components to support your GLP-1 product development needs:
- Pre-filled syringe (PFS) plungers
- Rigid needle shields (RNS)
- Cartridge plungers for pen-injectors
Take your development from formulation to patient with Aptar Pharma’s drug development services, innovative solutions and patient services that support the success of your self-injected GLP-1 drug products for diabetes and obesity.
Ensure your long-term security of supply of GLP-1 injectable components
With a growing market for diabetes and obesity treatments, securing your long-term security of supply of GLP-1 self-injection components is essential. We continue to expand our injectable component manufacturing capabilities, leveraging robotization and clean room manufacturing capacity to ensure you receive ever-increasing quality worldwide.
With a new factory in Europe, new manufacturing lines in the US and worldwide upgrade plans, we are investing in capabilities to support your drug developments needs and transform your expectations of what an injectable partner should be.
Accelerate and derisk your GLP-1 drug and delivery device development
When developing glucagon-like peptide-1 (GLP-1) drugs, such as for diabetes or obesity, the compatibility of the formulation with the primary container is a major concern that could potentially delay regulatory approval.
Leverage Aptar Pharma’s pure rubber component formulation, market proven component designs and clean room manufacturing capabilities to promote drug to component compatibility. For your most sensitive drug development programs, choose PremiumCoat® ETFE film-coated plungers to further reduce the risks related to extractables, and leachables.
Facilitate your choice of primary packaging
Selecting the right primary packaging partner is essential to derisk your regulatory review and reduce time-to-market. World-leading glass-manufacturing and pharmaceutical companies have already validated our pre-filled syringe component solutions and are partnering with us to develop self-injection devices for glucagon-like peptide-1 (GLP-1) and a wide range of other applications.
Support your brand image and differentiate your GLP-1 drug
As GLP-1 drugs are getting more attention and global competition increases, differentiation will become essential for the success of your injectable drug. Customize your parenteral drug delivery solutions with us, meeting your specific requirements and supporting your brand image.
World Leading Rigid Needle Shield (RNS) Solutions
Accelerate your injectable GLP-1 product development with our world leading RNS solutions for ½” needles and specialized designs for auto-injectors. Customize your RNS to your specific requirements and GLP-1 drug delivery needs.
Secure your long-term supply of GLP-1 injector components with our new manufacturing lines, robotization and state-of-the-art processes that ensure reproducibility and quality.
Platform of Syringe and Cartridge Plungers
Accelerate and derisk your GLP-1 drug development and injectable reformulation project with our platform of GLP-1 pre-filled syringe (PFS) plunger and cartridge plunger components that leverage our pure bromobutyl composition.
This rubber formulation is also used for our PremiumCoat® line of ETFE film-coated plungers, that ensure the maximum protection of sensitive drug product. PremiumCoat®’s proprietary 3-rib design also helps to ensure optimal system performance and seamless integration with GLP-1 auto-injectors.
Advanced Parenteral Closure Solutions
Further derisk your injectables manufacturing and support your compliance with EU Annex 1 regulations by combining our GLP-1 compatible syringe plungers with our Advanced Parenteral Closure Solutions:
- PremiumFill®: reduced contamination and particulate specifications.
- Ready-to-use: gamma sterilized components with guarantee of sterility at time of use.
- Rapid Transfer Port bags: RTP bags support aseptic transfer of components on filling lines.
- Vision control: further improve contamination and defect specifications.
Drug Development Services
Trust the experts from Aptar Pharma to support your GLP-1 injectable drug development project and validate your choice of primary packaging. Gateway Analytical’s services help to derisk and accelerate your drug product development with:
- Extractables & Leachables studies
- Particulate Analysis
- Validation of primary packaging solutions across multiple parameters (container closure integrity, functional testing, shipping studies…)
Patient Services
Ensure the success of your injectable drug beyond the development stages and partner with Aptar Digital Health and Noble to optimize the therapeutic outcome for your GLP-1 patients. Our Human Factor studies, drug delivery training kits and digital health solutions enhance patient engagement and adherence, which are critical for the efficiency of chronic diabetes and obesity treatments.
Product Details
Contact Aptar Pharma’s Parenteral Expert Team Today
Learn more about how we can support your compliance with EMA GMP Annex 1 revisions and optimize your operations with our advanced injectable packaging solutions.
Recently Published Resources
Exploring Extractable and Leachable Testing Strategies for Parenterals
Publications, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions
Elevating Medication Adherence and Clinical Outcomes with Connected Drug Delivery
Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation
Aptar Pharma Injectable Expansion – Capacity, Capabilities and Partnership
Publications, Pharmaceutical, Product Solutions, Market Insights
Injectable Primary Packaging support compliance with Annex 1 Revision
Publications, Pharmaceutical, Market Insights, Product Solutions, Brand Differentiation
